Foresti V, Parisio E, Tronci M, Casati O, Zubani R, Pedretti D
Divisione medica III, Ospedale Fatebenefratelli e Oftalmico, Presidio multizonale ospedaliero dell'E.R.S.Z., U.S.S.L. 75/1, Milano.
Recenti Prog Med. 1990 Oct;81(10):661-2.
EDTA-induced pseudothrombocytopenia is a laboratory artifact caused in vitro by platelet aggregation, due to IgG or IgM class antibodies reacting with antigenic binding site of the GP IIb glycoprotein. Pseudothrombocytopenia is rarely found (about 1% of platelets counts), but must be considered in the differential diagnosis of thrombocytopenia, since it could lead to useless investigations and therapies. We report three patients with pseudothrombocytopenia, one of whom underwent bone marrow biopsy and danazol treatment, before establishing the correct diagnosis. The absence of hemorrhagic manifestations with persisting low platelets counts led to a re-examination of peripheral blood smear and to the diagnosis of pseudothrombocytopenia. Therefore a morphological platelets evaluation and their count on citrate-anticoagulated blood must be performed in every patient under assessment for thrombocytopenia.
乙二胺四乙酸(EDTA)诱导的假性血小板减少症是一种体外由血小板聚集引起的实验室假象,这是由于IgG或IgM类抗体与糖蛋白IIb(GP IIb)的抗原结合位点发生反应所致。假性血小板减少症很少见(约占血小板计数的1%),但在血小板减少症的鉴别诊断中必须予以考虑,因为它可能导致不必要的检查和治疗。我们报告了3例假性血小板减少症患者,其中1例在确立正确诊断之前接受了骨髓活检和达那唑治疗。在血小板计数持续偏低但无出血表现的情况下,重新检查外周血涂片后诊断为假性血小板减少症。因此,对于每一位接受血小板减少症评估的患者,都必须对枸橼酸盐抗凝血液中的血小板进行形态学评估及其计数。